ANI Pharmaceuticals, Inc. ANIP
NASDAQ · United States · Health Technology
$72.96+0.31 (+0.43%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-07 | 2.21 | 2.04 | +8.2% | $266.04M | +2.3% | -8.3%$82.63→$75.76 |
| Q1 2026 | 2026-05-08 | 2.05 | 1.30 | +57.7% | — | — | -6.2%$83.91→$78.71 |
| Q4 2025 | 2026-02-27 | 2.33 | 1.98 | +17.7% | — | — | -2.5%$77.15→$75.22 |
| Q3 2025 | 2025-11-07 | 2.04 | 1.77 | +15.3% | — | — | -1.4%$90.23→$88.93 |
| Q2 2025 | 2025-08-08 | 1.80 | 1.42 | +26.8% | — | — | — |
| Q1 2025 | 2025-05-09 | 1.70 | 1.38 | +23.2% | — | — | — |
| Q4 2024 | 2025-02-28 | 1.63 | 1.44 | +13.2% | — | — | — |
| Q3 2024 | 2024-11-08 | 1.34 | 1.09 | +22.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.